Compass Pathways Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Compass Pathways PLC ADR CMPS
News
Compass Pathways to Participate in Stifel 2026 Healthcare Conference on November 11th
Compass Pathways Announces Third Quarter 2026 Financial Results and Business Highlights
New Joint Survey from Compass Pathways and the Depression and Bipolar Support Alliance Reveals the Lived Burden of Treatment-Resistant Depression on Patients and Caregivers
Compass Pathways to Highlight Scientific Research and TRD Disease State Education Efforts at the 2026 Neuroscience Education Institute Fall Congress
Compass Pathways to Announce Third Quarter 2026 Financial Results on November 3, 2026
Compass Pathways Joins Forces with Leading Mental Health Organizations to Mark First-Ever U.S. Treatment-Resistant Depression (TRD) Awareness Day
Compass Pathways Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Compass Pathways Appoints Kelley Boucher as Chief People Officer
Compass Pathways to Participate in TD Cowen 6th Annual Novel Mechanisms in Neuropsychiatry Summit on September 23, 2026
Compass Pathways Launches ‘Change the Tune in TRD’ in the U.S. to Advance HCP Understanding of Treatment-Resistant Depression at Psych Congress 2026
Fluence Selected by Compass Pathways to Develop Post-Approval COMP360 Provider Training
Compass Pathways Announces U.S. Grant Program Recipients for the Development of Post-Approval COMP360 Provider Training
Compass Pathways to Participate in Investor Conferences the Week of September 14th
Compass Pathways’ New 52-Week Topline Open-Label Data from Phase 3 COMP005 Trial Demonstrates Additional Benefit from Another COMP360 Dose in Part C Extending Durability Out to 1 Year
Compass Pathways to Debut U.S. HCP Education Campaign and Present New HEOR Data at Psych Congress 2026
Compass Pathways Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Compass Pathways Recognized as a 2026 Fierce 50 Breakthrough Honoree
Compass Pathways to Participate in 2026 Cantor Global Healthcare Conference on September 9, 2026
Psychedelic stocks surge after Trump supports using drugs like LSD for mental health
United States